Sanofi India Ltd Share Price & Stock Analysis

Sanofi India Ltd (BSE: 500674) is a Mumbai, Maharashtra-based company in the Pharmaceuticals industry. With a market capitalisation of ₹7,564 Cr, it ranks #682 by market cap among the 6,197 Indian listed companies on FinBizNet, and #14 of 63 in Pharmaceuticals. At ₹3,300.00 (as of 16 Nov 2026), the share price is 29.0% below its 52-week high of ₹4,650.00 and 19.6% above its 52-week low of ₹2,758.20. The share price is down 30.4% over one year and up 1.6% over three months.

Key Metrics

Current Price₹3,300.00
Market Cap₹7,564 Cr
BSE Code500674
SectorHealth Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals
Sub-IndustryBiotechnology and Life Sciences > Pharmaceuticals
P/E Ratio23.1
Return on Equity40.59%
Return on Assets19.81%
52-Week Range₹2,758.20 – ₹4,650.00
1-Year Price Change-30.4%
3-Month Price Change+1.6%
Beta (1Y)0.32
Dividend Yield4.57%
HeadquartersMumbai, Maharashtra
Websitewww.sanofi.com/en/india/investors

Latest Quarterly Results — Q2 FY27

Revenue₹492 Cr
Net Profit₹117 Cr
Net Margin23.7%
EPS (Basic)₹50.67
Basisstandalone

Figures in ₹ crore, parsed from the company's exchange filing (XBRL).

Sanofi India Ltd Quarterly Revenue and Profit Trend

Sanofi India Ltd reported revenue of ₹492 Cr in Q2 FY27, up 3.4% from ₹475 Cr in Q2 FY26 and up 12.3% from ₹438 Cr in Q1 FY27. It posted a net profit of ₹117 Cr for the quarter, against a net profit of ₹76 Cr in Q2 FY26 (up 53.6%). Across the 7 quarters from Q4 FY25 to Q2 FY27, quarterly revenue ranged from ₹406 Cr (Q1 FY26) to ₹536 Cr (Q4 FY25). The company was profitable in each of these 7 quarters.

QuarterRevenueNet ProfitNet Margin
Q2 FY27₹492 Cr₹117 Cr23.7%
Q1 FY27₹438 Cr₹84 Cr19.1%
Q4 FY26₹472 Cr₹103 Cr21.7%
Q3 FY26₹420 Cr₹62 Cr14.7%
Q2 FY26₹475 Cr₹76 Cr16.0%
Q1 FY26₹406 Cr₹70 Cr17.1%
Q4 FY25₹536 Cr₹120 Cr22.3%

Standalone figures (₹ crore, XBRL filings).

Shareholding and Delivery

Promoters held 60.40% of Sanofi India Ltd's shares as of Sept 2026, unchanged from Sept 2025. Delivery averaged 46.3% of traded volume across 16 NSE sessions (22 Oct 2026 – 13 Nov 2026).

About Sanofi India Ltd

Sanofi India Limited manufactures and trades in drugs and pharmaceutical products in India, Singapore and internationally. The company provides pharmaceutical products in various therapeutic areas, such as diabetes, cardiology, thrombosis, infections, epilepsy, anti-infectives, and central nervous system, as well as allergy, pain care, digestive, and nutritional health under the Lantus, Toujeo, Soliqua, Clexane, Amaryl, Cardace, Lasix, Lasilactone, Glimepiride, Cetapin, Targocid, Frisium, Targocio, Combiflam, DePura, Allegra, Baralgan, BUSCOGAST, Dulcoflex, Enterogermina, Novalgin, and Avil brands through independent distributors. It also exports its products to approximately 24 countries. The company was formerly known as Aventis Pharma Limited and changed its name to Sanofi India Limited in May 2012. The company was incorporated in 1956 and is headquartered in Mumbai, India. Sanofi India Limited is a subsidiary of Hoechst GmbH.

Products and Services

1. Pharmaceutical Business-This segment offers pharmaceutical and related products.

Business Segments

1. Pharmaceutical Business-100%

Sanofi India Ltd vs Peers — Pharmaceuticals

CompanyMarket CapP/EROELatest Qtr Revenue1Y Change
Abbott India Ltd.₹56,531 Cr36.334.46%₹1,814 Cr-8.1%
Emcure Pharmaceuticals Ltd₹42,344 Cr47.919.57%₹2,820 Cr+73.3%
Ajanta Pharma Limited₹41,474 Cr39.425.39%₹1,794 Cr+27.8%
Piramal Pharma Ltd₹32,600 Crn/m-4.00%₹2,617 Cr+22.8%
RUBICON RESEARCH LIMITED₹28,526 Cr112.319.14%₹576 Cr+162.7%
Caplin Point Laboratories Ltdte₹18,155 Cr28.319.94%₹630 Cr+23.6%
Pfizer Ltd.₹17,811 Cr24.517.16%₹727 Cr-24.2%
Eris Lifesciences Ltd₹17,691 Cr28.318.07%₹892 Cr-17.5%
Sanofi India Ltd₹7,564 Cr23.140.59%₹492 Cr-30.4%

Listed by market capitalisation. Ratios are shown for context only.

Frequently Asked Questions

What is the current share price of Sanofi India Ltd?

Sanofi India Ltd is trading at ₹3,300.00, with a market capitalisation of ₹7,564 Cr.

Which sector does Sanofi India Ltd belong to?

Sanofi India Ltd operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Biotechnology and Life Sciences > Pharmaceuticals).

What are the key financial ratios of Sanofi India Ltd?

Sanofi India Ltd has a P/E of 23.1 and a return on equity of 40.59%.

What is the stock symbol of Sanofi India Ltd?

Sanofi India Ltd is listed on the BSE under the scrip code 500674.

How has Sanofi India Ltd's share price moved over the past year?

Sanofi India Ltd's share price is down 30.4% over one year and up 1.6% over three months. Its 52-week range is ₹2,758.20 to ₹4,650.00.

What were Sanofi India Ltd's latest quarterly results?

In Q2 FY27, Sanofi India Ltd reported revenue of ₹492 Cr and net profit of ₹117 Cr, with basic EPS of ₹50.67 (standalone, parsed from the company's exchange filing).

How have Sanofi India Ltd's revenue and profit changed over the past year?

Sanofi India Ltd reported revenue of ₹492 Cr in Q2 FY27, up 3.4% from ₹475 Cr in Q2 FY26 and up 12.3% from ₹438 Cr in Q1 FY27.

What is the promoter holding in Sanofi India Ltd?

Promoters held 60.40% of Sanofi India Ltd's shares as of Sept 2026, unchanged from Sept 2025.

More on FinBizNet

Data as of 16 Nov 2026. Descriptive market data only — not investment advice.